US2774321002 - Common Stock

Taking everything into account, **EMN** scores **4** out of 10 in our fundamental rating. **EMN** was compared to 85 industry peers in the **Chemicals** industry. There are concerns on the financial health of **EMN** while its profitability can be described as average. **EMN** is valued correctly, but it does not seem to be growing.

In the past year **EMN** had a positive cash flow from operations.

In the past 5 years **EMN** has always been profitable.

Each year in the past 5 years **EMN** had a positive operating cash flow.

Looking at the **Return On Equity**, with a value of **10.93%**, **EMN** is in line with its industry, outperforming **58.33%** of the companies in the same industry.

The **Average Return On Invested Capital** over the past 3 years for **EMN** is in line with the industry average of **7.81%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 4.01% | ||

ROE | 10.93% | ||

ROIC | 6.62% |

ROA(3y)4.63%

ROA(5y)5.08%

ROE(3y)12.78%

ROE(5y)13.94%

ROIC(3y)8.81%

ROIC(5y)8.42%

Looking at the **Profit Margin**, with a value of **6.24%**, **EMN** is in the better half of the industry, outperforming **60.71%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 10.81% | ||

PM (TTM) | 6.24% | ||

GM | 21.04% |

OM growth 3Y-4.15%

OM growth 5Y-5.98%

PM growth 3Y-2.89%

PM growth 5Y-12.36%

GM growth 3Y-5.71%

GM growth 5Y-3.98%

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), **EMN** is creating some value.

Compared to 1 year ago, **EMN** has less shares outstanding

Compared to 1 year ago, **EMN** has a worse debt to assets ratio.

The Debt to FCF ratio of **EMN** is **10.03**, which is on the high side as it means it would take **EMN**, **10.03** years of fcf income to pay off all of its debts.

The **Debt to Equity ratio** of **EMN** (**0.93**) is worse than **65.48%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.93 | ||

Debt/FCF | 10.03 | ||

Altman-Z | 2.49 |

ROIC/WACC0.81

WACC8.17%

Looking at the **Current ratio**, with a value of **1.36**, **EMN** is doing worse than **84.52%** of the companies in the same industry.

A Quick Ratio of **0.71** indicates that **EMN** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.36 | ||

Quick Ratio | 0.71 |

The **Earnings Per Share** has been growing slightly by **0.55%** on average over the past years.

Looking at the last year, **EMN** shows a very negative growth in **Revenue**. The Revenue has decreased by **-13.99%** in the last year.

Measured over the past years, **EMN** shows a small growth in **Revenue**. The Revenue has been growing by **2.07%** on average per year.

EPS 1Y (TTM)-31.66%

EPS 3Y3.22%

EPS 5Y0.55%

EPS growth Q2Q-28.29%

Revenue 1Y (TTM)-13.99%

Revenue growth 3Y4.49%

Revenue growth 5Y2.07%

Revenue growth Q2Q-16.32%

The **Revenue** is expected to decrease by **-1.74%** on average over the next years.

EPS Next Y-17.59%

EPS Next 2Y0.95%

EPS Next 3Y5.3%

EPS Next 5Y7.64%

Revenue Next Year-13.3%

Revenue Next 2Y-5.2%

Revenue Next 3Y-1.75%

Revenue Next 5Y-1.74%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

With a **Price/Earnings** ratio of **14.19**, **EMN** is valued correctly.

Compared to the rest of the industry, the **Price/Earnings** ratio of **EMN** indicates a somewhat cheap valuation: **EMN** is cheaper than 64.29% of the companies listed in the same industry.

Based on the **Price/Forward Earnings** ratio, **EMN** is valued a bit cheaper than 78.57% of the companies in the same industry.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **20.05**, **EMN** is valued a bit cheaper.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 14.19 | ||

Fwd PE | 10.63 |

Based on the **Enterprise Value to EBITDA** ratio, **EMN** is valued a bit cheaper than 64.29% of the companies in the same industry.

61.90% of the companies in the same industry are more expensive than **EMN**, based on the **Price/Free Cash Flow** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 19.35 | ||

EV/EBITDA | 9.56 |

PEG (NY)N/A

PEG (5Y)26.03

EPS Next 2Y0.95%

EPS Next 3Y5.3%

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.81% |

The dividend of **EMN** is nicely growing with an annual growth rate of **8.48%**!

Dividend Growth(5Y)8.48%

Div Incr Years10

Div Non Decr Years10

The dividend of **EMN** is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP63.76%

EPS Next 2Y0.95%

EPS Next 3Y5.3%

**EASTMAN CHEMICAL CO**

NYSE:EMN (12/8/2023, 7:04:00 PM)

After market: 84.85 0 (0%)**84.85**

**-0.22 (-0.26%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap10.06B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.81% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 14.19 | ||

Fwd PE | 10.63 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)26.03

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 4.01% | ||

ROE | 10.93% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 10.81% | ||

PM (TTM) | 6.24% | ||

GM | 21.04% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.64

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.93 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.36 | ||

Quick Ratio | 0.71 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-31.66%

EPS 3Y3.22%

EPS 5Y

EPS growth Q2Q

EPS Next Y-17.59%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-13.99%

Revenue growth 3Y4.49%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y